Donneau, A.-F.* , Guillaume, M.* , BOURS, V., Dandoy, M., DARCIS, G., Desmecht, D., Diep, A. N., Fievez, L., Garigliany, M.-M., Gillain, N., Husson, E., Michel, F., MOUTSCHEN, M., Paridans, M., Pétré, B., Sabatel, C., Saegerman, C., Tytgat, A., Gillet, L.* , & Bureau, F.*. (2022). University population-based prospective cohort study of SARS-CoV- 2 infection and immunity (SARSSURV-ULiège): a study protocol. BMJ Open. doi:10.1136/bmjopen-2021-055721 * These authors have contributed equally to this work. |
Pétré, B., Paridans, M., Gillain, N., Husson, E., Donneau, A.-F., Dardenne, N., Breuer, C., Michel, F., Dandoy, M., Bureau, F., Gillet, L., Leclercq, D., & Guillaume, M. (2022). Factors influencing the adoption and participation rate of nursing homes staff in a saliva testing screening programme for COVID-19. PLoS ONE, 17 (6), 0270551. doi:10.1371/journal.pone.0270551 |
Pétré, B., Paridans, M., Gillain, N., Husson, E., Donneau, A.-F., Dardenne, N., Breuer, C., Michel, F., Dandoy, M., Bureau, F., Gillet, L., Leclercq, D., & Guillaume, M. (2022). Acceptability of Community Saliva Testing in Controlling the COVID-19 Pandemic: Lessons Learned from Two Case Studies in Nursing Homes and Schools. Patient Preference and Adherence, 16, 625-631. doi:10.2147/PPA.S349742 |
Saegerman, C., Nguyet Diep, A., Renault, V., Donneau, A.-F., Stamatakis, L., Coppieters, W., Michel, F., Breuer, C., Dandoy, M., Ek, O., Gourzonès, C., Schyns, J., Goffin, E., Minner, F., Durkin, K., Artesi, M., Bours, V., Bureau, F., & Gillet, L. (2022). A 2-month field cohort study of SARS-CoV-2 in saliva of BNT162b2 vaccinated nursing home workers. Communications Medicine. doi:10.1038/s43856-021-00067-3 |
Saegerman, C., Donneau, A.-F., Speybroeck, N., Diep, A. N., Williams, A., Stamatakis, L., Coppieters, W., Michel, F., Breuer, C., Dandoy, M., Ek, O., Gourzonès, C., Schyns, J., Goffin, E., Minner, F., Renault, V., Gillet, L.* , & Bureau, F.*. (2021). Repetitive saliva-based mass screening as a tool for controlling SARS-CoV-2 transmission in nursing homes. Transboundary and Emerging Diseases. doi:10.1111/tbed.14280 * These authors have contributed equally to this work. |